Brief: Armas Pharmaceuticals Announcing Launch Of Oncology Injectable Irinotecan
07/05/2019 13:52
May 7 (Reuters) - Yakult Honsha Co Ltd 2267.T :
* ARMAS PHARMACEUTICALS - ANNOUNCING LAUNCH OF ONCOLOGY
INJECTABLE
IRINOTECAN
* ARMAS PHARMACEUTICALS - ONCOLOGY INJECTABLE IRINOTECAN IS
THE
THERAPEUTIC EQUIVALENT OF CAMPTOSAR, A TRADEMARK OF YAKULT
HONSHA COMPANY LTD
Source text for Eikon: ID:nPn5TXS06a
Further company coverage: 2267.T
(Reuters.Briefs@thomsonreuters.com)
Recent news on Yakult Honsha
See all newsBrief: Dalton Investments Sends Letter To Yakult Honsha
Table: Yakult -Q1 group results
To Cancel 5.53 Million Shares, 1.79% Of Outstanding Shares, On June 30
Japanese firms field record proposals from activists at this year's shareholder meetings
Brief: Murakami-Linked City Index Eleventh Takes 1.6% Stake In Yakult Honsha Co, AGM Notice Shows